Efficacy of Faricimab in the Treatment of Diabetic Macular Edema and Faricimab-Related Changes in OCT and OCT Angiography
Our study aimed to assess the anatomical changes in the retina, including the assessment of the reduction of diabetic macular edema (DME) on optical coherence tomography (OCT) and the improvement of retinal microvascular parameters, defined by the reduction of nonperfusion areas on OCT angiography (...
Saved in:
| Main Authors: | Dorota Śpiewak, Łukasz Drzyzga, Mariola Dorecka, Katarzyna Witek, Dorota Wyględowska-Promieńska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/7/858 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spectral OCT Angiography in the Assessment of Biomarkers of Diabetic Macular Edema in Navigation Laser Treatment
by: P. L. Volodin, et al.
Published: (2022-07-01) -
Two-year results of switching to intravitreal administration of faricimab in patients with aflibercept-refractory neovascular age-related macular degeneration
by: Masaaki Saito, et al.
Published: (2025-08-01) -
Effect of Faricimab versus Aflibercept on Hyperreflective Foci in Patients with Diabetic Macular Edema from the YOSEMITE/RHINE Trials
by: Usha Chakravarthy, FRCOphth, PhD, et al.
Published: (2025-09-01) -
Serum Apolipoprotein B and B/A1 Ratio as Early Negative Biomarkers for OCT- and OCTA-Detected Retinal Changes in Diabetic Macular Edema
by: Soedarman S, et al.
Published: (2025-07-01) -
Short-term outcomes of faricimab and aflibercept 8 mg in diabetic macular edema
by: Carlo Maccauro, et al.
Published: (2025-07-01)